S-nitrosylation of C-Src Via NMDAR-nNOS Module Promotes C-Src Activation and NR2A Phosphorylation in Cerebral Ischemia/reperfusion

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2012 Mar 17

PMID 22422045

Citations 7

Authors

Li-Juan Tang

Chong Li

Shu-Qun Hu

Yong-Ping Wu

Yan-Yan Zong

Chang-Cheng Sun

Fa Zhang

Guang-Yi Zhang

Affiliations

Soon will be listed here.

Abstract

Previous studies suggested that activated c-Src promote the tyrosine phosphorylation of NMDA receptor subunit NR2A, and thus aggravate the injury induced by transient cerebral ischemia/reperfusion (I/R) in rat hippocampus CA1 region. In this study, we examined the effect of nitric oxide (NO) on the activation of c-Src and the tyrosine phosphorylation of NMDA receptor NR2A subunit. The results show that S-nitrosylation and the phosphorylation of c-Src were induced after cerebral I/R in rats, and administration of nNOS inhibitor 7-NI, nNOS antisense oligonucleotides and exogenous NO donor sodium nitroprusside diminished the increased S-nitrosylation and phosphorylation of c-Src during cerebral I/R. The cysteine residues of c-Src modified by S-nitrosylation are Cys489, Cys498, and Cys500. On the other hand, NMDAR antagonist MK-801 could attenuate the S-nitrosylation and activation of c-Src. Taken together, the S-nitrosylation of c-Src is provoked by NO derived from endogenous nNOS, which is activated by Ca(2+) influx from NMDA receptors, and promotes the auto-phosphorylation at tyrosines and further phosphorylates NR2A. The molecular mechanism we outlined here is a novel postsynaptic NMDAR-nNOS/c-Src-mediated signaling amplification, the 'NMDAR-nNOS → NO → SNO-c-Src → p-c-Src → NMDAR-nNOS' cycle, which presents the possibility as a potential therapeutic target for stroke treatment.

Citing Articles

The Influence of Oxidative Stress Markers in Patients with Ischemic Stroke.

Pawluk H, Tafelska-Kaczmarek A, Soponska M, Porzych M, Modrzejewska M, Pawluk M Biomolecules. 2024; 14(9).

PMID: 39334896 PMC: 11430825. DOI: 10.3390/biom14091130.

Roles of Nitric Oxide in Brain Ischemia and Reperfusion.

Wang Y, Hong F, Yang S Int J Mol Sci. 2022; 23(8).

PMID: 35457061 PMC: 9028809. DOI: 10.3390/ijms23084243.

Probiotics decrease depressive behaviors induced by constipation via activating the AKT signaling pathway.

Xu N, Fan W, Zhou X, Liu Y, Ma P, Qi S Metab Brain Dis. 2018; 33(5):1625-1633.

PMID: 29948655 DOI: 10.1007/s11011-018-0269-4.

Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease.

Maubert M, Wigdahl B, Nonnemacher M Front Neurosci. 2017; 11:228.

PMID: 28491017 PMC: 5405129. DOI: 10.3389/fnins.2017.00228.

Neuroprotective Effects of Inhibiting Fyn S-Nitrosylation on Cerebral Ischemia/Reperfusion-Induced Damage to CA1 Hippocampal Neurons.

Hao L, Wei X, Guo P, Zhang G, Qi S Int J Mol Sci. 2016; 17(7).

PMID: 27420046 PMC: 4964476. DOI: 10.3390/ijms17071100.

References

Lipton S, Rosenberg P . Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994; 330(9):613-22. DOI: 10.1056/NEJM199403033300907. View

Rahman M, Senga T, Ito S, Hyodo T, Hasegawa H, Hamaguchi M . S-nitrosylation at cysteine 498 of c-Src tyrosine kinase regulates nitric oxide-mediated cell invasion. J Biol Chem. 2009; 285(6):3806-3814. PMC: 2823522. DOI: 10.1074/jbc.M109.059782. View

Hou X, Zhang G, Zong Y . Suppression of postsynaptic density protein 95 expression attenuates increased tyrosine phosphorylation of NR2A subunits of N-methyl-D-aspartate receptors and interactions of Src and Fyn with NR2A after transient brain ischemia in rat hippocampus. Neurosci Lett. 2003; 343(2):125-8. DOI: 10.1016/s0304-3940(03)00365-3. View

Jaffrey S, Erdjument-Bromage H, Ferris C, Tempst P, Snyder S . Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol. 2001; 3(2):193-7. DOI: 10.1038/35055104. View

Iadecola C . Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 1997; 20(3):132-9. DOI: 10.1016/s0166-2236(96)10074-6. View

Wenthold R, Prybylowski K, Standley S, Sans N, Petralia R . Trafficking of NMDA receptors. Annu Rev Pharmacol Toxicol. 2003; 43:335-58. DOI: 10.1146/annurev.pharmtox.43.100901.135803. View

Hess D, Matsumoto A, Kim S, Marshall H, Stamler J . Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol. 2005; 6(2):150-66. DOI: 10.1038/nrm1569. View

Park H, Huh S, Kim M, Lee S, Choi E . Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc Natl Acad Sci U S A. 2000; 97(26):14382-7. PMC: 18927. DOI: 10.1073/pnas.97.26.14382. View

Ali D, Salter M . NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol. 2001; 11(3):336-42. DOI: 10.1016/s0959-4388(00)00216-6. View

10.

Watanabe M, Inoue Y, Sakimura K, Mishina M . Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport. 1992; 3(12):1138-40. DOI: 10.1097/00001756-199212000-00027. View

11.

Lennmyr F, Ericsson A, Gerwins P, Akterin S, Ahlstrom H, Terent A . Src family kinase-inhibitor PP2 reduces focal ischemic brain injury. Acta Neurol Scand. 2004; 110(3):175-9. DOI: 10.1111/j.1600-0404.2004.00306.x. View

12.

Choi D . Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988; 1(8):623-34. DOI: 10.1016/0896-6273(88)90162-6. View

13.

Noguchi S, Jianmongkol S, Bender A, Kamada Y, Demady D, Osawa Y . Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase. J Biol Chem. 2000; 275(4):2376-80. DOI: 10.1074/jbc.275.4.2376. View

14.

Farrokhnia N, Roos M, Terent A, Lennmyr F . Experimental treatment for focal hyperglycemic ischemic brain injury in the rat. Exp Brain Res. 2005; 167(2):310-4. DOI: 10.1007/s00221-005-0157-0. View

15.

Chen M, Hou X, Zhang G . Tyrosine kinase and tyrosine phosphatase participate in regulation of interactions of NMDA receptor subunit 2A with Src and Fyn mediated by PSD-95 after transient brain ischemia. Neurosci Lett. 2003; 339(1):29-32. DOI: 10.1016/s0304-3940(02)01439-8. View

16.

Ogita K, Yoneda Y . Selective potentiation of DNA binding activities of both activator protein 1 and cyclic AMP response element binding protein through in vivo activation of N-methyl-D-aspartate receptor complex in mouse brain. J Neurochem. 1994; 63(2):525-34. DOI: 10.1046/j.1471-4159.1994.63020525.x. View

17.

Zheng X, RESNICK R, Shalloway D . A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. EMBO J. 2000; 19(5):964-78. PMC: 305636. DOI: 10.1093/emboj/19.5.964. View

18.

Dawson V, Dawson T . Free radicals and neuronal cell death. Cell Death Differ. 1996; 3(1):71-8. View

19.

Forrester M, Foster M, Stamler J . Assessment and application of the biotin switch technique for examining protein S-nitrosylation under conditions of pharmacologically induced oxidative stress. J Biol Chem. 2007; 282(19):13977-83. DOI: 10.1074/jbc.M609684200. View

20.

Abu-Soud H, Wang J, Rousseau D, Fukuto J, Ignarro L, Stuehr D . Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis. J Biol Chem. 1995; 270(39):22997-3006. DOI: 10.1074/jbc.270.39.22997. View